MDXG

3.0501.93%
JH

John Harper

SVP of R&D & Medical Affairs and Chief Scientific Officer

Dr. John Harper, Ph.D., is SVP of R&D & Medical Affairs and Chief Scientific Officer at MiMedx Group, Inc. He is Chairman of Scientific Advisory Board of StemBioSys, Inc. He served as Chief Technology Officer and Senior Vice President of Research and Product Development at MiMedx Group, Inc. since June 2021 until April 2023. He serves as Senior Vice President and Chief Technology Officer at Acelity (formally Kinetic Concepts, Inc.). He previously served as KCI’s Senior Vice President of Advanced Research and Technology. He has devoted his career to health and life sciences. He served as Vice President of Clinical Sciences at LifeCell Corp., the leader in acellular scaffold technology and maker of the Graftjacket regenerative tissue matrix. After LifeCell was acquired by KCI, he joined the R&D side of the team. He serves as Chairman of Advisory Board at StemBioSys, Inc. He has 40 peer-reviewed publications and book chapters to his credit, with his Principal areas of research including extracellular matrix biochemistry and wound healing. He received his Ph. D. in biomedical science from The University of Texas M. D. Anderson Cancer Center in Houston and completed postdoctoral training in cancer biochemistry and cell biology at Scripps Clinic in La Jolla, California and the National Cancer Institute in Bethesda, Maryland.

Positions